Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -52.452% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) Cc1cc(Br)cc(Cl)c1OC(=O)c1cnccn1
(b) Cc1ccc(S(=O)(=O)N2CCCC2CNC(=O)c2ccc(F)c(F)c2)cc1
Answer: b. Cc1ccc(S(=O)(=O)N2CCCC2CNC(=O)c2ccc(F)c(F)c2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCCC2CNC(=O)c2ccc(F)c(F)c2)cc1
Cc1ccc(S(=O)(=O)N2CCCC2CNC(=O)c2ccc(F)c(F)c2)cc1
4,5-difluoro-N-[[1-(4-methylphenyl)sulfonylpyrrolidin-2-yl]methyl]benzamide